-
Nanjing Rongjiekang RC1416 dual antibo©™dy has obtained 2 clinical trial lice©α₹®nses againTime of issue : 2025- 01-03Recently, Nanjing RegeneCore '∏ ☆Biotechnology Co., Ltd.'s RC1416 p<≈↕roject has consecutively♥™¥ obtained Investigational New Drug (IND)←♣¥← approvals from the National Med≈<ical Products Administration&φ♦¥α#039;s Center for Drug Evaluation (CD♠₽γE) for indications of atopic d♠↔"ermatitis (AD) and chronic obstructiveε÷β pulmonary disease (COPD). The expansion of< ¥§ these indications has further diversifie✔' d the clinical application scenarios oγ>¶♦f RC1416 injection, providing better↕•♠♠ treatment options for more patient<↔≥πs..
-
融捷集團：競逐新賽道(dào)，勇攀生(shēng)命科(kē)技(jì)高(gā←÷'o)峰Time of issue : 2024- 12-02近(jìn)日(rì)，南京博爾迪生物科技有限公司發布的(de)一(yī)≥↓®則招募中重度哮喘患者的(de)消息引人(r♠<÷★én)關注。原來(lái)，由融捷康自(zì)研的(>'σβde)國(guó)內(nèi)首個(gè)自(zì)免雙特異性納米抗體$÷(tǐ)藥物(wù)——RC1416注射液，正在全∏£↕國(guó)數(shù)十家(jiā)知↓γσ(zhī)名醫(yī)院開(kāi)展臨床研究。這(zhè)款雙抗藥✔©品在藥效、安全性和(hé)成藥性等多(duō)重指标上(shàng)具有(yǒ₹★u)較好(hǎo)的(de)優勢，未來(≈¥₹≈lái)有(yǒu)望成為(wèi)中重度哮喘患者的(de)福音(yīn)。
-
Recruitment of Patients with Moderat∏σe to Severe AsthmaTime of issue : 2024- 11-26RC1416 injection, developed by Nanjing RegeneCor±<e Biotech Co.,Ltd, is currently und↑ergoing a Phase Ib clinical stud☆♣₽₽y to "evaluate the safety, t¥olerability, pharmacokinetics, pharmacody Ω☆namics, immunogenicity, and preli₩§minary effectiveness₽≥ of RC1416 injection in patients with mo÷&♣✘derate to severe asthma." The α♣lead institution for this study is the←♥φ§ China-Japan Friendship Hospital in Beij→→γ→ing, and it is simultaneously being conduc≤∑±ted at dozens of renowned hospitals across the↑• country.
-
Lv Xiangyang Visited Nanjing Re↑♠genecore and Thoth InstitutesTime of issue : 2024- 09-19Lv Xiangyang visited Nanjing Rege ©necore & Thoth Institutes, assessing deve∞♦lopments & future developλ★♠ment direction.
TEL：
Address: Room 07 Buildin€σg 16 Treehouse, No. 73, Tanmi Road,€≠ Jiangbei New District, Nanjing
Enterprise email：rjk@regenecore.com
WeChat cooperative consultation
You are the th visitor
025-58608860 
Contact 